{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T08:04:14Z","timestamp":1785225854403,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1007\/s11882-005-0044-6","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T23:30:13Z","timestamp":1180827013000},"page":"243-251","source":"Crossref","is-referenced-by-count":35,"title":["Therapeutic approaches to mucus hypersecretion"],"prefix":"10.1007","volume":"5","author":[{"given":"Atsushi","family":"Yuta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James N.","family":"Baraniuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"44_CR1","first-page":"2703","volume":"36","author":"L Reid","year":"1977","unstructured":"Reid L: Secretory Cells. Fed Proc 1977, 36:2703\u20132707.","journal-title":"Fed Proc"},{"key":"44_CR2","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/BF00731215","volume":"11","author":"M Verma","year":"1994","unstructured":"Verma M, Davidson EA: Mucin gene: structure, expression, and regulation. Glycoconjugate J 1994, 11:172\u2013179.","journal-title":"Glycoconjugate J"},{"key":"44_CR3","first-page":"28","volume-title":"Immunology of the Lung and Upper Respiratory Tract","author":"C Brandtzaeg","year":"1984","unstructured":"Brandtzaeg C: Immune functions of human nasal mucosa and tonsils in health and disease. In Immunology of the Lung and Upper Respiratory Tract. Edited by Bienenstock J. New York: McGraw-Hill; 1984:28\u201395."},{"key":"44_CR4","first-page":"1","volume-title":"Drugs in Bronchial Mucology","year":"1989","unstructured":"Braga PC, Allegra L (eds): Drugs in Bronchial Mucology. New York: Raven Press; 1989:1\u2013368. Although an older reference, this remains the best review of all pharmacologic approaches used to address mucus hypersecretion and expectoration."},{"key":"44_CR5","volume-title":"Respiratory Pharmacology and Therapeutics","author":"I Ziment","year":"1988","unstructured":"Ziment I: Respiratory Pharmacology and Therapeutics. Philadelphia: WB Saunders; 1988."},{"key":"44_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-0348-8874-5","volume-title":"Airway Mucus: Basic Mechanisms and Clinical Perspectives","author":"DF Rogers","year":"1997","unstructured":"Rogers DF, Lethem MI (eds): Airway Mucus: Basic Mechanisms and Clinical Perspectives. Basel: Birkhauser; 1997:1\u2013388."},{"key":"44_CR7","first-page":"6","volume":"2","author":"HY Hsu","year":"1977","unstructured":"Hsu HY, Peacher WG, Chen H: History of Chinese medical science. Bull Orient Arts Inst 1977, 2:6.","journal-title":"Bull Orient Arts Inst"},{"key":"44_CR8","volume-title":"The Healing Hand, Man, and Wound in the Ancient World","author":"G Majno","year":"1975","unstructured":"Majno G: The Healing Hand, Man, and Wound in the Ancient World. Cambridge: Harvard University Press; 1975."},{"key":"44_CR9","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S0140-6736(87)90066-3","volume":"8527","author":"KF Chung","year":"1987","unstructured":"Chung KF, Dent G, McCusker M, et al.: Effect of a ginkgolide mixture, BN 52063, in antagonizing skin and platelet response to platelet activating factor. Lancet 1987, 8527:248\u2013251.","journal-title":"Lancet"},{"key":"44_CR10","first-page":"71","volume":"70","author":"P Richardson","year":"1987","unstructured":"Richardson P: Oral N-acetyl-cystine: How does it act? Eur J Resp Dis 1987, 70:71\u201372.","journal-title":"Eur J Resp Dis"},{"issue":"Suppl 111","key":"44_CR11","first-page":"127","volume":"61","author":"U Stephan","year":"1980","unstructured":"Stephan U, Bowing B, Goering U, et al.: Acetylcysteine in chronic treatment of cystic fibrosis. Eur J Respir Dis 1980, 61(Suppl 111):127\u2013131.","journal-title":"Eur J Respir Dis"},{"key":"44_CR12","first-page":"405","volume":"64","author":"G Boman","year":"1983","unstructured":"Boman G, Backer U, Larsson S, et al.: Oral acetyl cystine reduces exacerbation rate in chronic bronchitis, report of a trial organized by the Swedish Society for Pulmonary Disease. Eur J Resp Dis 1983, 64:405\u2013415.","journal-title":"Eur J Resp Dis"},{"issue":"Suppl 111","key":"44_CR13","first-page":"93","volume":"61","author":"Multicenter Study Group","year":"1980","unstructured":"Multicenter Study Group: Long term oral acetyl cystine in chronic bronchitis, a double blind controlled study. Eur J Respir Dis 1980, 61(Suppl 111):93\u2013108.","journal-title":"Eur J Respir Dis"},{"key":"44_CR14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/jcp.20066","volume":"201","author":"T Rochat","year":"2004","unstructured":"Rochat T, Lacroix JS, Jornot L: N-acetylcysteine inhibits Na+ absorption across human nasal epithelial cells. J Cell Physiol 2004, 201:106\u2013116.","journal-title":"J Cell Physiol"},{"key":"44_CR15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/cpt1974161part158","volume":"16","author":"SN Steen","year":"1974","unstructured":"Steen SN, Ziment I, Freeman D, Thomas JS: Evaluation a new mucolytic drug. Clin Pharmacol Ther 1974, 16:58\u201362.","journal-title":"Clin Pharmacol Ther"},{"key":"44_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ab.2004.08.003","volume":"335","author":"B Boonyapiwat","year":"2004","unstructured":"Boonyapiwat B, Forbes B, Steventon GB: Phenylalanine hydroxylase: possible involvement in the S-oxidation of Scarboxymethyl-l-cysteine. Anal Biochem 2004, 335:91\u201397.","journal-title":"Anal Biochem"},{"key":"44_CR17","first-page":"88","volume":"79","author":"G Miskovits","year":"1984","unstructured":"Miskovits G, Szule P, Appel J, Meszaros M: La mucoregolation element important dans le traitement du syndrome bronchitique. Med Klin 1984, 79:88\u201392.","journal-title":"Med Klin"},{"key":"44_CR18","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3109\/00016489009124812","volume":"471","author":"Y Majima","year":"1990","unstructured":"Majima Y, Takeuchi K, Sakakura Y: Effects of myringotomy and orally administered drugs on viscosity and elasticity of middle ear effusions from children with otitis media with effusion. Acta Otolaryngol Suppl (Stockh) 1990, 471:66\u201372.","journal-title":"Acta Otolaryngol Suppl (Stockh)"},{"key":"44_CR19","first-page":"CD001831","volume":"4","author":"K Schroeder","year":"2004","unstructured":"Schroeder K, Fahey T: Over-the-counter medications for acute cough in children and adults in ambulatory settings. Cochrane Database Syst Rev 2004, 4:CD001831. A recent review and metaanalyses of commonly used therapies.","journal-title":"Cochrane Database Syst Rev"},{"key":"44_CR20","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.2169\/internalmedicine.43.1034","volume":"43","author":"T Tsujimoto","year":"2004","unstructured":"Tsujimoto T, Takano M, Tsuruzono T, et al.: Mediastinal pancreatic pseudocyst caused by obstruction of the pancreatic duct was eliminated by bromhexine hydrochloride. Intern Med 2004, 43:1034\u20131038.","journal-title":"Intern Med"},{"key":"44_CR21","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s10238-004-0050-3","volume":"4","author":"V Stetinova","year":"2004","unstructured":"Stetinova V, Herout V, Kvetina J: In vitro and in vivo antioxidant activity of ambroxol. Clin Exp Med 2004, 4:152\u2013158.","journal-title":"Clin Exp Med"},{"key":"44_CR22","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1378\/chest.98.5.1309-b","volume":"98","author":"TL Petty","year":"1990","unstructured":"Petty TL: The national mucolytic study: results of a randomized, double blind, placebo controlled study of iodinated glycerol in chronic obstructive bronchitis. Chest 1990, 98:1309\u20131310.","journal-title":"Chest"},{"key":"44_CR23","first-page":"139","volume":"36","author":"S Ferrari","year":"1981","unstructured":"Ferrari S, Donati C, Legnani W: Studio clinico controllato dell\u2019attivata terapeutica del domiodolo. Riv Patol Clin 1981, 36:139\u2013154.","journal-title":"Riv Patol Clin"},{"key":"44_CR24","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1053\/rmed.2003.1432","volume":"97","author":"UR Juergens","year":"2003","unstructured":"Juergens UR, Dethlefsen U, Steinkamp G, et al.: Anti-inflammatory activity of 1,8-cineol (eucalyptol) in bronchial asthma: a double-blind placebo-controlled trial. Respir Med 2003, 97:250\u2013256. The recent increase in interest in COPD has spurred properly designed studies to investigate specific drugs. Here, the active ingredient in eucalyptus preparations was shown to have a beneficial effect.","journal-title":"Respir Med"},{"key":"44_CR25","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/0091-6749(92)90123-J","volume":"90","author":"EO Meltzer","year":"1992","unstructured":"Meltzer EO: Intranasal anticholinergic therapy of rhinorrhea. J Allergy Clin Immunol 1992, 90:1055\u20131064.","journal-title":"J Allergy Clin Immunol"},{"key":"44_CR26","first-page":"535","volume-title":"Pulmonary and Critical Care Pharmacology and Therapeutics","author":"NJ Gross","year":"1996","unstructured":"Gross NJ: Anticholinergic agents. In Pulmonary and Critical Care Pharmacology and Therapeutics. Edited by Leff AR. New York: McGraw-Hill; 1996:535\u2013552."},{"key":"44_CR27","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1152\/physrev.00034.2003","volume":"84","author":"FL Ricciardolo","year":"2004","unstructured":"Ricciardolo FL, Sterk PJ, Gaston B, Folkerts G: Nitric oxide in health and disease of the respiratory system. Physiol Rev 2004, 84:731\u2013765.","journal-title":"Physiol Rev"},{"key":"44_CR28","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1164\/arrd.1984.129.5.871","volume":"129","author":"TJ Gal","year":"1984","unstructured":"Gal TJ, Suratt PM, Lu J: Glycopyrrolate and atropine inhalation: comparative effects on normal airway function. Am Rev Respir Dis 1984, 129:871\u2013873.","journal-title":"Am Rev Respir Dis"},{"key":"44_CR29","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/S0091-6749(95)70215-6","volume":"95","author":"EA Bronsky","year":"1995","unstructured":"Bronsky EA, Druce H, Findlay SR, et al.: A clinical trial of ipratropium bromide nasal spray in patients with perennial nonallergic rhinitis. J Allergy Clin Immunol 1995, 95:1117\u20131122.","journal-title":"J Allergy Clin Immunol"},{"key":"44_CR30","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S0091-6749(95)70219-9","volume":"95","author":"L Diamond","year":"1995","unstructured":"Diamond L, Dockhorn RJ, Grossman J, et al.: A dose-response study of the efficacy and safety of ipratropium bromide nasal spray in the treatment of the common cold. J Allergy Clin Immunol 1995, 95:1139\u20131146.","journal-title":"J Allergy Clin Immunol"},{"key":"44_CR31","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0012-3692(15)37387-6","volume":"74","author":"K Saketkhoo","year":"1978","unstructured":"Saketkhoo K, Januskiewicz A, Sackner MA: Effects of drinking hot water, cold water, and chicken soup on nasal mucus, velocity and nasal airflow resistance. Chest 1978, 74:408\u2013410.","journal-title":"Chest"},{"key":"44_CR32","first-page":"CD001127","volume":"3","author":"AP Jones","year":"2003","unstructured":"Jones AP, Wallis CE: Recombinant human deoxyribonuclease for cystic fibrosis. Cochrane Database Syst Rev 2003, 3:CD001127.","journal-title":"Cochrane Database Syst Rev"},{"key":"44_CR33","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1126\/science.8310295","volume":"263","author":"CA Vasconcellos","year":"1994","unstructured":"Vasconcellos CA, Allen PG, Wohl ME, Stossel TP: Reduction in viscosity of cystic fibrosis sputum in vitro by gelsolin. Science 1994, 263:969\u2013971.","journal-title":"Science"},{"key":"44_CR34","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1136\/thx.50.8.880","volume":"50","author":"T Brandt","year":"1995","unstructured":"Brandt T, Breitenstein S, Hardt HV, T\u00fcmmler B: DNA concentration and length in sputum of patients with cystic fibrosis during inhalation with recombinant human DNase. Thorax 1995, 50:880\u2013882.","journal-title":"Thorax"},{"key":"44_CR35","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/0091-6749(94)90154-6","volume":"94","author":"DM Claman","year":"1994","unstructured":"Claman DM, Bousher HA, Lui J, et al.: Analysis of induced sputum to examine the effects of prednisone on airway inflammation in asthmatic subjects. J Allergy Clin Immunol 1994, 94:861\u2013869.","journal-title":"J Allergy Clin Immunol"},{"key":"44_CR36","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1164\/ajrccm\/141.1.72","volume":"141","author":"SK Goswami","year":"1990","unstructured":"Goswami SK, Kivity S, Marom Z: Erythromycin inhibits respiratory glycoconjugate secretion from human airway in vivo. Am Rev Respir Dis 1990, 141:72\u201378.","journal-title":"Am Rev Respir Dis"},{"key":"44_CR37","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1183\/09031936.93.05020234","volume":"5","author":"J Tamaoki","year":"1992","unstructured":"Tamaoki J, Isono K, Sakai N, et al.: Erythromycin inhibits Cl secretion across canine tracheal epithelial cells. Eur Respir J 1992, 5:234\u2013238.","journal-title":"Eur Respir J"},{"issue":"2 Suppl","key":"44_CR38","doi-asserted-by":"publisher","first-page":"52S","DOI":"10.1378\/chest.125.2_suppl.52S","volume":"125","author":"MH Gotfried","year":"2004","unstructured":"Gotfried MH: Macrolides for the treatment of chronic sinusitis, asthma, and COPD. Chest 2004, 125(2 Suppl):52S-60S. Macrolides have had many effects in vitro and apparently in vivo. The nonantibiotic properties of specific macrolides and the general class are discussed as well as the place of these antibiotics for each condition.","journal-title":"Chest"},{"key":"44_CR39","first-page":"1070","volume":"97","author":"Y Iino","year":"1994","unstructured":"Iino Y, Okura S, Shiga J, et al.: Histopathological studies on paranasal mucosa from patients treated with erythromycin. J Otolaryngol Jpn 1994, 97:1070\u20131078.","journal-title":"J Otolaryngol Jpn"},{"key":"44_CR40","doi-asserted-by":"crossref","unstructured":"Anonymous: Diquafosol: DE 089, diquafosol tetrasodium, INS 365, INS 365 Ophthalmic, INS 365 Respiratory, KPY 998. Drugs R D 2003, 4:359-362.","DOI":"10.2165\/00126839-200304060-00005"},{"key":"44_CR41","first-page":"367","volume":"2","author":"PJ Poole","year":"2003","unstructured":"Poole PJ, Black PN: Preventing exacerbations of chronic bronchitis and COPD: therapeutic potential of mucolytic agents. Am J Respir Crit Care Med 2003, 2:367\u2013370. This recent review suggests a possible role of mucolytic and other agents for reducing exacerbation rates in COPD.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-005-0044-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11882-005-0044-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-005-0044-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-005-0044-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T04:30:29Z","timestamp":1683865829000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11882-005-0044-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["44"],"URL":"https:\/\/doi.org\/10.1007\/s11882-005-0044-6","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}